Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
To evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of CC-90005 in healthy subjects and subjects with moderate to severe plaque-type psoriasis.
Epistemonikos ID: 80588a4ef491e566f72772b2804e95099975657b
First added on: May 12, 2024